Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torsten Zuberbier

Showing results (401-410 of 423) with videos related to

Pageof 43
Sort By:
Allergologie Select|September 11, 2020
Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic: Position paper of Ärzteverband Deutscher Allergologen (AeDA)<sup>A</sup>, Deutsche Gesellschaft für Allergologie und Klinische Immunologie (DGAKI)<sup>B</sup>, Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA)<sup>C</sup>, Österreichische Gesellschaft für Allergologie und Immunologie (ÖGAI)<sup>D</sup>, Luxemburgische Gesellschaft für Allergologie und Immunologie (LGAI)<sup>E</sup>, Österreichische Gesellschaft für Pneumologie (ÖGP)<sup>F</sup> in co-operation with the German, Austrian, and Swiss ARIA groups<sup>G</sup>, and the European Academy of Allergy and Clinical Immunology (EAACI)<sup>H</sup>Ludger Klimek, Oliver Pfaar, Margitta Worm, et al.
Allergy|April 8, 2019
2019 ARIA Care pathways for allergen immunotherapyJean Bousquet, Oliver Pfaar, Alkis Togias, et al.
The World Allergy Organization Journal|April 24, 2026
The definition of response and inadequate response to topical corticosteroid treatment in atopic dermatitis and related skin inflammatory diseases: A GA<sup>2</sup>LEN ADCARE statement paperTorsten Zuberbier, Mohamed Abuzakouk, Irena Angelova Fischer, et al.
Clinical and Translational Allergy|November 26, 2022
Real-world data using mHealth apps in rhinitis, rhinosinusitis and their multimorbiditiesBernardo Sousa-Pinto, Aram Anto, Markus Berger, et al.
Allergy|March 17, 2021
Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA<sup>2</sup> LEN consensusJan Hagemann, Gabrielle L Onorato, Marek Jutel, et al.
The Journal of Allergy and Clinical Immunology|October 20, 2019
Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidenceJean Bousquet, Holger J Schünemann, Akdis Togias, et al.
Allergy|December 7, 2020
The global impact of the COVID-19 pandemic on the management and course of chronic urticariaEmek Kocatürk, Andaç Salman, Ivan Cherrez-Ojeda, et al.
Allergy|April 12, 2023
Patient-centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA-EAACI approach - ARIA-EAACI Task Force ReportJean Bousquet, Mohamed H Shamji, Josep M Anto, et al.
Clinical and Translational Allergy|September 25, 2023
A concept for integrated care pathways for atopic dermatitis-A GA<sup>2</sup> LEN ADCARE initiativeTorsten Zuberbier, Amir Abdul Latiff, Xenofon Aggelidis, et al.
The Journal of Allergy and Clinical Immunology|October 2, 2018
Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technologyJean Bousquet, Peter W Hellings, Ioana Agache, et al.
Pageof 43

Showing results (401-410 of 423) with videos related to

Sort By:
Pageof 43
Allergologie Select|September 11, 2020
Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic: Position paper of Ärzteverband Deutscher Allergologen (AeDA)<sup>A</sup>, Deutsche Gesellschaft für Allergologie und Klinische Immunologie (DGAKI)<sup>B</sup>, Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA)<sup>C</sup>, Österreichische Gesellschaft für Allergologie und Immunologie (ÖGAI)<sup>D</sup>, Luxemburgische Gesellschaft für Allergologie und Immunologie (LGAI)<sup>E</sup>, Österreichische Gesellschaft für Pneumologie (ÖGP)<sup>F</sup> in co-operation with the German, Austrian, and Swiss ARIA groups<sup>G</sup>, and the European Academy of Allergy and Clinical Immunology (EAACI)<sup>H</sup>Ludger Klimek, Oliver Pfaar, Margitta Worm, et al.
Allergy|April 8, 2019
2019 ARIA Care pathways for allergen immunotherapyJean Bousquet, Oliver Pfaar, Alkis Togias, et al.
The World Allergy Organization Journal|April 24, 2026
The definition of response and inadequate response to topical corticosteroid treatment in atopic dermatitis and related skin inflammatory diseases: A GA<sup>2</sup>LEN ADCARE statement paperTorsten Zuberbier, Mohamed Abuzakouk, Irena Angelova Fischer, et al.
Clinical and Translational Allergy|November 26, 2022
Real-world data using mHealth apps in rhinitis, rhinosinusitis and their multimorbiditiesBernardo Sousa-Pinto, Aram Anto, Markus Berger, et al.
Allergy|March 17, 2021
Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA<sup>2</sup> LEN consensusJan Hagemann, Gabrielle L Onorato, Marek Jutel, et al.
The Journal of Allergy and Clinical Immunology|October 20, 2019
Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidenceJean Bousquet, Holger J Schünemann, Akdis Togias, et al.
Allergy|December 7, 2020
The global impact of the COVID-19 pandemic on the management and course of chronic urticariaEmek Kocatürk, Andaç Salman, Ivan Cherrez-Ojeda, et al.
Allergy|April 12, 2023
Patient-centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA-EAACI approach - ARIA-EAACI Task Force ReportJean Bousquet, Mohamed H Shamji, Josep M Anto, et al.
Clinical and Translational Allergy|September 25, 2023
A concept for integrated care pathways for atopic dermatitis-A GA<sup>2</sup> LEN ADCARE initiativeTorsten Zuberbier, Amir Abdul Latiff, Xenofon Aggelidis, et al.
The Journal of Allergy and Clinical Immunology|October 2, 2018
Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technologyJean Bousquet, Peter W Hellings, Ioana Agache, et al.
Pageof 43